Summary. Rabbits were given 50 i.u. hCG, i.v., to initiate ovulation and pseudopregnancy (Day 0) and were treated, s.c., with or without a 1-cm Silastic oestradiol implant. Serum progesterone concentrations were measured at 4-day intervals and 3-hydroxy-3-methylglutaryl\p=n-\coenzyme A (HMG\p=n-\CoA) reductase activity was estimated by the conversion of HMG to mevalonate in microsomes from corpora lutea removed on Days 4, 8, 12, 16 and 20 of pseudopregnancy (4 rabbits/day). Total HMG\p=n-\CoAreductase activity was significantly (P < 0\m=.\05)higher in control rabbits on Days 8 and 12 (5\m=.\29 \m=+-\0\m=.\63 and 5\ m=. \ 5\m=+-\0\m=.\28 nmol/min/mg protein, respectively) compared to oestradioltreated rabbits (2\m=.\57\ m=+-\ 0\m=.\25and 4\m=.\03\ m=+-\ 0\m=.\23nmol/min/mg protein, respectively). On Days 16 and 20, total HMG\p=n-\CoAreductase activity was not different in control and oestradiol-treated animals. There was no difference in the levels of the active fraction of HMG\p=n-\CoA reductase, which represented <20% of the total enzyme activity, in control and oestradiol-treated rabbits (<780 pmol/min/mg protein, Day 12). These results indicate that oestradiol does not alter the active form, but can reduce the total activity of HMG\p=n-\CoAreductase in the rabbit corpus luteum without a decline in serum progesterone. Therefore, neither total nor active forms of HMG\p=n-\CoAreductase are directly related to progesterone secretion. This suggests that other sources of cholesterol may contribute to progesterone production in the rabbit.
Introduction
As early as 1933, Schoenheimer & Breusch (1933) had deduced that cholesterol regulated its own synthesis. The enzyme responsible for this process was found to be 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase (EC 1.1.1.34), the rate-limiting enzyme for de-novo choles¬ terol biosynthesis (Shapiro & Rodwell, 1972) . This enzyme occurs exclusively in the microsomal membrane fraction of cell homogenates, with over 80% of the enzyme being associated with the smooth endoplasmic reticulum, Golgi and plasma membrane (Goldfarb, 1972) . HMG-CoA reduc¬ tase exists in an active (dephosphorylated) and an inactive (phosphorylated) form (Beg & Brewer, 1978) .
Several hormones have been implicated in the regulation of HMG-CoA reductase. Those that increase HMG-CoA reductase activity include insulin (White, 1972) , thyroid hormone (Guder et al, 1968) , adrenaline and noradrenaline (Edwards, 1973) . Hormones which have been shown to decrease HMG-CoA reductase include glucagon (Huber et al, 1973) and the glucocorticoids (Dugan et al, 1974) . The sex steroids, oestrogens, progestagens and androgens, can also suppress *Reprint requests to Dr J. B. Miller. reductase activity of human fibroblasts when added to culture medium or hepatic reductase activity when fed or injected into rats or mice (Mukherjee & Bhose, 1968 ; Kandutsch & Packie, 1970) . In contrast, oestradiol stimulates HMG-CoA reductase activity in uterine epithelial cells (Wilce et al, 1984) and rat corpora lutea (Azhar et al, 1985) . This suggests that oestradiol may regulate HMG-CoA reductase activity differently in target tissues that have high oestrogen receptor levels than in non-target tissues.
Oestradiol is the principal luteotrophic hormone in the rabbit, and it can maintain the usual patterns of serum progesterone concentrations during pseudopregnancy in the hypophysectomized animal (Bill & Keyes, 1983) . Although it is presumed that oestradiol acts via an oestrogen receptor to regulate luteal function (Mills & Osteen, 1977; Miller & Keyes, 1978; Miller & Toft, 1983) , the cellular mechanisms through which oestradiol regulates steroidogenesis in this tissue are as yet unknown. In the rabbit corpus luteum, the level of HMG-CoA reductase activity peaks on (Kovanen et al, 1978) . Coincident with the decrease in HMG-CoA reductase activity is an increase in oestradiol binding in corpora lutea (Mills & Osteen, 1977; Miller & Toft, 1983 ) and a decrease in plasma cholesterol (Zilversmit et al, 1972) . These changes occur within a span of 2-3 days during early luteal development. This suggests that oestradiol may regulate de-novo cholesterol synthesis or its utilization by the corpus luteum. The purpose of the present study was therefore to examine the effect of (1) oestradiol on HMG-CoA reductase activity during pseudopregnancy and (2) decreased serum cholesterol concentrations on luteal HMG-CoA reductase activity and progesterone pro¬ duction in the rabbit. Some of the results have been presented in abstract form (McLean & Miller, 1986b [l,2,6,7-3] progesterone and [2,4,6,7-3H(N) (1974) . Each sample was extracted with benzene and chromatographed on Sephadex LH-20 columns using a benzene:methanol (9:1, v/v) solvent system (Carr et al, 1971) . Samples were assayed in duplicate at 4°C and incubated with antibody (final dilution of 1:120000) and [3H]oestradiol. Bound ligand was separated from free by charcoal absorption (0-25% Norit A and 0025% dextran T70 in PBS). This assay has a sensitivity of 0-2-0-3pg, and an average 50% inhibition point of 12-15 pg. The mass of oestradiol in each sample was corrected for procedural losses (recoveries averaged 65%) and oestradiol was expressed as pg/ml serum.
Serum progesterone determination. Progesterone concentrations were measured throughout pseudopregnancy (Days 0, 4, 8, 12, 16, 20) by the radioimmunoassay described by Day & Birnbaumer (1980) . The antiserum used (GDN No. 337) was raised in rabbits against progesterone-11-chloroformate conjugated to bovine serum albumin and has been characterized by Gibori et al (1977) . Each sample was extracted into hexane and assayed in duplicate with [3H]progesterone and antibody (final dilution of 1:5000). Bound ligand was separated from free by charcoal (0-25% Norit A and 0-25% dextran T70). Results were calculated using the logit-log weighted-linear regression program of Rodbard et al (1980) . The inter-and intra-assay coefficients of variation were 5-9% (n = 22) and 7-4, 6-5 and 3-6% at 20,45 and 60% binding, respectively (n = 10). Serum progesterone concentrations from each rabbit have been normalized assuming 10 CL per animal.
Determination of HMG-CoA reductase. Activity was measured by the method of Kovanen et al. (1978) with slight modifications. Rabbit ovaries were removed after cervical dislocation and placed in cold HBSS (4°C). Corpora lutea were dissected out on ice and 3-6 corpora lutea were homogenized in 1 ml buffer containing 0-3 M-sucrose, 25 mM-2-mercaptoethanol, 5mM-dithiothreitol, 10mM-EDTA, and either 50mM-NaCl or 50mM-NaF (pH 70). Sodium fluoride was included in the homogenization buffer to inhibit protein phosphatase activity which activates the HMGCoA reductase (Ingebritsen et al, 1981) . Thus, corpora lutea isolated in 50 mM-NaCl buffer represents an estimation of the total HMG-CoA reductase activity whereas luteal tissue isolated in 50 mM-NaF buffer represents an estimation of the active enzyme level. The homogenization was performed at 4°C with a Dounce homogenizer using 20 strokes each with a loose and tight fitting pestle. The resulting homogenate was centrifuged at 20 000 g for 20 min to remove unbroken cells and nuclei and the supernatant was centrifuged at 100 000 g for 60 min to isolate luteal microsomes. The microsomes were resuspended in 10 ml buffer containing 0T M-potassium phosphate (pH 7-5) and 5 mMdithiothreitol. A fraction of the resuspended microsomes (10 µ ) was used to estimate protein content using the tech¬ nique of Bradford (1976 4-Aminopyrazolo(3,4-d) pyrimidine administration. 4-Aminopyrazolo(3,4-d) pyrimidine (APP) was used to determine the effect of reduced serum cholesterol concentrations (Morrin el al, 1979) on progesterone production and HMG-CoA reductase activity in oestrogen-treated rabbits. On Days 9-11, oestrogen-treated rabbits were injected with APP (25 mg/ml in saline, 10 mg/kg, pH 2-5) or saline administered i.p. Daily blood samples were taken just before each APP injection for the determination of serum cholestrol and progesterone. Rabbits were killed on Day 12 and the corpora lutea removed for HMG-CoA reductase determination.
Dissociation of rabbit luteal tissue and incubation with compactin. Corpora lutea were dissected on Day 10 of pseudopregnancy and dissociated as previously described (McLean & Miller, 1985) . The dissociation medium con¬ tained 250 U collagenase/ml, 50 µg DNase/ml, 750 µg trypsin inhibitor/ml, 20 mg BSA/ml, and 100 µg gentamicin/ml in HBSS.
Dissociated luteal cells were incubated (100 000 cells/ml) for 1 h in HBSS (6 ml) gassed with 95% 02 and 5% C02 at 37°C and then 0-10 µg compactin/ml was added for 4 additional hours of incubation. Media fractions (1 ml) containing cells and medium were removed each hour, cells were separated by centrifugation (500 # for 5 min) and the media stored for progesterone analysis.
Statistical analysis. Results are expressed as the mean + s.e.m. Values were compared by analysis of variance and, when significant differences were noted, groups were compared using Student-Newman-Keuls multiple comparison test (Zar, 1974 4 Day 8 Day 12 Day 16 Day 16 Day 20
Progesterone (ng/ml) (Fig. 1 Effect of lower serum cholesterol on HMG-CoA reductase activity Rabbits treated with APP had significantly (P < 005) lower serum cholesterol concentrations compared to control animals (23-8 ± 7-2 ví 601 + 18-9 mg/dl, respectively, Day 12). Since choles¬ terol measurements were made 24 h after APP administration, the cholesterol values in APPtreated animals represent the highest levels reached during drug treatment. There was, however, no change in the serum progesterone concentrations (14-8 + 3-6 vs 17-9 + 2-4 ng/ml in APP-treated and control rabbits, Day 12). The total activity of HMG-CoA reductase increased slightly with APP treatment, but this change was not significant (4-28 + 0-66 vs 5-2 + 0-5 nmol/min/protein). In contrast, there was a significant (P < 005) increase in the active form of HMG-CoA reductase in luteal microsomes on Day 12 of pseudopregnancy from rabbits treated with APP (0-90 + 0T 4 vs 1-82 + 0-26 nmol/min/mg/protein).
Inhibition of HMG-CoA reductase in vitro
The addition of compactin (0001-10 pg/ml), a competitive inhibitor of HMG-CoA reductase (Kaneko et al, 1978; Silavin & Strauss, 1983) , had no effect on progesterone secretion by dissociated 27-0 ± 3-9 21-2 ± 3-4 20-9 ± 3-4 26-7 ± 4-9 28-2 ± 4-9
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luteal cells during 4 h of incubation (n = 5; Table 2 ). Progesterone concentrations in media from compactin-treated incubations were not significantly different from control incubations at any compactin concentration tested.
Discussion
It is well-established that functional luteal cells must have an efficient means of obtaining choles¬ terol for steriodogenesis (Strauss et al, 1981) . The rabbit corpus luteum contains high levels of the rate-limiting enzyme of cholesterol synthesis, HMG-CoA reductase, which suggests that de-novo cholesterol synthesis may be the essential pathway through which rabbit luteal cells acquire choles¬ terol for progesterone production. Since the activity of this enzyme begins to decline after Day 5 of pregnancy (Kovanen et al, 1978) at the time when oestradiol binding to corpora lutea is first observed (Mills & Osteen, 1977) , we have examined the possibility that oestradiol regulates the activity of this enzyme during pseudopregnancy. In this study, we found that, when serum oestra¬ diol concentrations were elevated, the total activity of luteal HMG-CoA reductase was not altered during early pseudopregnancy (Day 4) (Carr et al, 1980) , was unaltered by oestradiol.
De-novo cholesterol synthesis did not seem to play a significant role during short term steroido¬ genesis in vitro since compactin was without effect on progesterone production by rabbit luteal cells during a 4-h incubation. Although we did not directly confirm that compactin inhibited HMGCoA reductase in our cells, the maximal dose of compactin used (10 µ ) was 3-7-fold the amount required to inhibit cholesterol synthesis in human fibroblasts (Kaneko et al, 1978) and human granulosa cells (Tureck & Strauss, 1982) . Similar results (i.e. failure to inhibit steroidogenesis with compactin) have been observed with hamster luteal and granulosa cells during short-term incubations (Silavin & Strauss, 1983) .
HMG-CoA reductase is regulated by two separate mechanisms which involve short-term modulation of the phosphorylated/dephosphorylated enzyme state, and long-term regulation of tissue enzyme concentrations (Beg & Brewer, 1981 (McLean & Miller, 1987) . Since oestrogen treatment did not alter serum cholesterol concentrations at any time throughout the experiment, increased cholesterol ester stores may have suppressed HMG-CoA reductase activity through feedback inhi¬ bition . This hypothesis is consistent with the findings of who showed that cholesterol ester levels were inversely related to reductase activity in cul¬ tured fibroblasts. In addition, it has been shown that the direct addition of cholesterol esters to cultured cells suppresses reductase activity more effectively than does cholesterol itself (Watson et al, 1974) .
Although oestradiol appears only to exert long-term regulation of rabbit luteal HMG-CoA reductase, this enzyme is also acutely affected by changes in serum cholesterol values. When serum cholesterol concentrations were decreased by APP (Morrin et al, 1979) in oestrogen-treated rabbits, the total enzyme activity increased only slightly while the active form of this enzyme was significantly ( < 005) elevated in APP-treated animals. These results suggest that HMG-CoA reductase activity increases to compensate for the loss of exogenous cholesterol. Similar results have been reported for rat luteal tissue after treatment with APP (Christie et al, 1979; Azhar & Menon, 1981 . Since HMG-CoA reductase activity increases in response to lowered serum cholesterol, it is clear that rabbit luteal tissue can utilize exogenous sources of cholesterol in situ.
This suggests that despite high levels of HMG-CoA reductase in the rabbit corpus luteum, lipoprotein-derived cholesterol can also be used as a substrate for steroidogenesis. This is consistent with our previous studies which demonstrate that both low-density lipoprotein and high-density lipoprotein can stimulate progesterone production by dissociated rabbit luteal cells in vitro (McLean & Miller, 1986a) . Thus, both de-novo-derived and lipoprotein-derived cholesterol appear to contribute to maintaining stable progesterone output by rabbit luteal cells.
From these results and those of our previous studies, we suggest that oestradiol indirectly con¬ trols HMG-CoA reductase by increasing cholesterol stores, thus decreasing luteal enzyme activity (long-term regulation). Short-term regulation of HMG-CoA reductase appears to be regulated by serum cholesterol concentrations. These results are consistent with the hypothesis that the luteotrophic role of oestrogen in the rabbit is to maintain a constant steroidogenic pool of cholesterol rather than to regulate directly de-novo cholesterol biosynthesis.
